Benzinga | May 4, 2021 09:29AM EDT

Oppenheimer Maintains Outperform on Itron, Lowers Price Target to $105

Oppenheimer analyst Noah Kaye maintains Itron (NASDAQ:ITRI) with a Outperform and lowers the price target from $127 to $105.